TY - JOUR
T1 - Mental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose
T2 - A cross-sectional questionnaire study in Japan
AU - the Positive SMBG Study Group Investigators
AU - Tanaka, Nagaaki
AU - Yabe, Daisuke
AU - Murotani, Kenta
AU - Ueno, Shinji
AU - Kuwata, Hitoshi
AU - Hamamoto, Yoshiyuki
AU - Kurose, Takeshi
AU - Takahashi, Nobuo
AU - Akashi, Tomoyuki
AU - Matsuoka, Takashi
AU - Osonoi, Takeshi
AU - Minami, Masae
AU - Shimono, Dai
AU - Seino, Yutaka
AU - Sekiguchi, Masatomo
AU - Hirota, Norihiko
AU - Yokoyama, Hiroki
AU - Uehara, Osamu
AU - Kanamori, Akira
AU - Kubota, Akira
AU - Ishitobi, Minori
AU - Nagayama, Koji
AU - Shibata, Taiga
AU - Yamamoto, Mayumi
AU - Hiraiwa, Yoshio
AU - Fukuda, Kazuhito
AU - Taniguchi, Takao
AU - Kuroe, Akira
AU - Kagimoto, Shinji
AU - Ihara, Yu
AU - Honjo, Sachiko
AU - Nishimura, Haruo
AU - Yasuda, Koichiro
AU - Muro, Seiji
AU - Ikeda, Hiroki
AU - Nakamura, Yoshio
AU - Kadowaki, Seizo
AU - Kawamoto, Seiichi
AU - Kashii, Saburo
AU - Fujimoto, Shinpei
AU - Matsuura, Bunzo
AU - Nakamura, Syuji
AU - Yokogawa, Yasushi
AU - Oida, Koji
AU - Iwamoto, Masahiro
AU - Kouchi, Yu
AU - Niiya, Tetsuji
AU - Furukawa, Makoto
AU - Satoh, Jo
N1 - Publisher Copyright:
© 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd
PY - 2018/9
Y1 - 2018/9
N2 - Aims/Introduction: The present multicenter, cross-sectional survey was initiated to evaluate self-monitoring of blood glucose (SMBG)-associated mental distress among patients with diabetes. Materials and Methods: The survey was carried out in patients with type 1 diabetes and type 2 diabetes using SMBG recruited from 42 medical institutions. Profiles of Mood States 2 and diabetes therapy-related quality of life questionnaires were used to evaluate mood status and health-related quality of life. Two original questionnaires were also developed to evaluate SMBG ‘importance,’ ‘painfulness’ and ‘confidence’ among patients, and to evaluate physician attitudes to SMBG use. Results: Questionnaires from 517 type 1 diabetes and 1,648 type 2 diabetes patients showed that 46.0% of type 1 diabetes and 37.5% of type 2 diabetes patients reported ‘painfulness,’ and that these patients reporting ‘painfulness’ showed significantly higher Profiles of Mood States 2 scores, lower diabetes therapy-related quality of life scores and higher glycated hemoglobin compared with those not reporting ‘painfulness,’ whereas the number of their daily SMBG tests were comparable. Patients reporting ‘painfulness’ also reported that SMBG use was significantly less important. Whether or not patients recognized the importance of SMBG use was well correlated with the frequency of physicians checking patient diaries. Conclusions: Type 1 diabetes and type 2 diabetes patients reporting ‘painfulness’ in SMBG use had more mental distress, lower health-related quality of life and higher glycated hemoglobin regardless of their number of daily SMBG tests. The importance of SMBG use was recognized less by patients experiencing pain, and the importance of SMBG use was recognized more in medical institutions in which physicians regularly checked SMBG diaries to provide meaningful feedback to patients in clinical settings.
AB - Aims/Introduction: The present multicenter, cross-sectional survey was initiated to evaluate self-monitoring of blood glucose (SMBG)-associated mental distress among patients with diabetes. Materials and Methods: The survey was carried out in patients with type 1 diabetes and type 2 diabetes using SMBG recruited from 42 medical institutions. Profiles of Mood States 2 and diabetes therapy-related quality of life questionnaires were used to evaluate mood status and health-related quality of life. Two original questionnaires were also developed to evaluate SMBG ‘importance,’ ‘painfulness’ and ‘confidence’ among patients, and to evaluate physician attitudes to SMBG use. Results: Questionnaires from 517 type 1 diabetes and 1,648 type 2 diabetes patients showed that 46.0% of type 1 diabetes and 37.5% of type 2 diabetes patients reported ‘painfulness,’ and that these patients reporting ‘painfulness’ showed significantly higher Profiles of Mood States 2 scores, lower diabetes therapy-related quality of life scores and higher glycated hemoglobin compared with those not reporting ‘painfulness,’ whereas the number of their daily SMBG tests were comparable. Patients reporting ‘painfulness’ also reported that SMBG use was significantly less important. Whether or not patients recognized the importance of SMBG use was well correlated with the frequency of physicians checking patient diaries. Conclusions: Type 1 diabetes and type 2 diabetes patients reporting ‘painfulness’ in SMBG use had more mental distress, lower health-related quality of life and higher glycated hemoglobin regardless of their number of daily SMBG tests. The importance of SMBG use was recognized less by patients experiencing pain, and the importance of SMBG use was recognized more in medical institutions in which physicians regularly checked SMBG diaries to provide meaningful feedback to patients in clinical settings.
UR - http://www.scopus.com/inward/record.url?scp=85044669167&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044669167&partnerID=8YFLogxK
U2 - 10.1111/jdi.12827
DO - 10.1111/jdi.12827
M3 - Article
C2 - 29493881
AN - SCOPUS:85044669167
SN - 2040-1116
VL - 9
SP - 1203
EP - 1211
JO - Journal of Diabetes Investigation
JF - Journal of Diabetes Investigation
IS - 5
ER -